Galapagos Adr (GLPG)

Currency: USD
GLPG
Time: 2025-07-03

28.83


High/Low: 29.23 / 28.58 Chg/Chg%: 0.28 / 0.98% Volume: 147602

GLPG NEWS

Galapagos NV (NASDAQ:GLPG) Shares Bought by GAMMA Investing LLC By MarketBeat - 1 week ago

GAMMA Investing LLC raised its holdings in Galapagos NV (NASDAQ:GLPG – Free Report) by 354.5% during the first quarter, Holdings Channel reports. The institutional investor owned 10,148 shares of the… [+3812 chars]...

Read more
Rhumbline Advisers Has $98,000 Stake in Galapagos NV (NASDAQ:GLPG) By MarketBeat - 1 week ago

Rhumbline Advisers trimmed its stake in shares of Galapagos NV (NASDAQ:GLPG – Free Report) by 19.4% during the first quarter, Holdings Channel.com reports. The firm owned 3,888 shares of the biotechn… [+3838 chars]...

Read more
Bank of America Corp DE Grows Position in Galapagos NV (NASDAQ:GLPG) By MarketBeat - 3 weeks ago

Bank of America Corp DE grew its stake in Galapagos NV (NASDAQ:GLPG – Free Report) by 19.6% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 22,454 shares of the biotechn… [+4134 chars]...

Read more
Galapagos (NASDAQ:GLPG) Shares Pass Above Two Hundred Day Moving Average – Here’s Why By MarketBeat - 2 weeks ago

Shares of Galapagos NV (NASDAQ:GLPG – Get Free Report) crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $26.12 and trade… [+3254 chars]...

Read more
Galapagos Appoints Aaron Cox as Chief Financial Officer By Galapagos - 1 week ago

Former Horizon CFO joins Galapagos with deep expertise in international corporate finance, M&A, business development and strategic leadership  Mechelen, Belgium; June 23, 2025, 07:30 CET; regula… [+5550 chars]...

Read more
Galapagos Presented New Data at ICML 2025 From Cohort 3 of ATALANTA-1 in Relapsed/Refractory Indolent NHL Patients, Demonstrating High Complete Response and MRD Negativity Rates With CAR-T Candidate GLPG5101 By Galapagos - 2 weeks ago

Of the 34 patients enrolled in Cohort 3 of the ATALANTA-1 Phase 1/2 study, 32 received GLPG5101; 94% were infused with fresh CAR-T cells, and 93% were treated within seven days of manufacturing GLPG… [+10331 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA
215.92 3.89
1.83%
CVX
148.37 0.39
0.26%
CAT
397.86 -0.57
-0.14%
INTC
22.49 0.61
2.79%
MSFT
498.84 7.75
1.58%
DIS
124 1.02
0.83%
DOW
28.46 -0.27
-0.94%
CSCO
69.37 0.78
1.14%
GS
723.68 7.79
1.09%